KRYS
Krystal Biotech Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$247.26
-4.05 ▼ -1.61%
🌙 3월 13일 7:45 PM ET (한국 3/14 08:45)
$253.00
+5.74 ▲ +2.32%
| Index | RUT | P/E | 36.13 | EPS (ttm) | 6.84 | Insider Own | 13.34% | Shs Outstand | 0.03B | Perf Week | -2.53% |
| Market Cap | 7.23B | Forward P/E | 24.53 | EPS next Y | 30.88% | Insider Trans | -6.12% | Shs Float | 0.03B | Perf Month | -9.31% |
| Enterprise Value | 6.41B | PEG | 0.97 | EPS next Q | 1.45 | Inst Own | 96.01% | Short Float | 11.64% | Perf Quarter | 3.15% |
| Income | 0.20B | P/S | 18.57 | EPS this Y | 12.62% | Inst Trans | -0.13% | Short Ratio | 10.08 | Perf Half Y | 71.28% |
| Sales | 0.39B | P/B | 5.92 | EPS next 5Y | 25.3% | ROA | 17.14% | Short Interest | 2.95M | Perf YTD | 0.29% |
| Book/sh | 41.78 | P/C | 8.73 | EPS past 3/5Y | - | ROE | 18.91% | 52W High | -17.11% ($298.30) | Perf Year | 39.4% |
| Cash/sh | 28.32 | P/FCF | 38.26 | Sales past 3/5Y | - | ROIC | 16.69% | 52W Low | 101.35% ($122.80) | Perf 3Y | 237.97% |
| Dividend Est. | - | EV/EBITDA | 38.22 | EPS Y/Y TTM | 127.79% | Gross Margin | 92.5% | Volatility(W/M) | 3.34% 4.28% | Perf 5Y | 198.59% |
| Dividend TTM | - | EV/Sales | 16.47 | Sales Y/Y TTM | 33.95% | Oper. Margin | 41.41% | ATR (14) | 10.92 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 9.56 | EPS Q/Q | 11.65% | Profit Margin | 52.64% | RSI (14) | 38.2 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 9.95 | Sales Q/Q | 17.52% | SMA20 | -6.92% ($265.64) | Beta | 0.54 | Target Price | $324 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 2000000 | SMA50 | -8.13% ($269.14) | Rel Volume | 0.98 | Prev Close | $251.31 |
| Employees | 295 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | 10.08% 1.67% | SMA200 | 25.66% ($196.77) | Avg Volume(3M) | 0.29M | Price | $247.26 |
| IPO | 2017/9/20 | Option/Short | Yes/Yes | Trades | 6659 | Volume | 286,777 | Change | -1.61% |
뉴스 로딩 중...